Breaking News - The Fly

Open Search

CLNN

Clene

$

()

Clene presents VISIONARY-MS long term extension study results

CLNN

4/16/2024 - 16:22pm

Clene announces peer-reviewed publication on CNM-Au8

CLNN

3/15/2024 - 08:20am

Clene expects cash to fund operations into 4Q24

CLNN

3/13/2024 - 08:09am

Clene reports 2023 EPS (47c), consensus (45c)

CLNN

3/13/2024 - 08:09am

Clene presents clinical results of CNM-Au8 30mg treatment

CLNN

2/29/2024 - 08:16am

Clene reports 'significant' survival results from two analyses of CNM-Au8

CLNN

2/22/2024 - 08:07am

Clene reports new CNM-Au8 results from VISIONARY-MS trial

CLNN

1/8/2024 - 07:27am

Clene announces new data from HEALEY ALS Platform Trial

CLNN

12/21/2023 - 07:09am

Clene announces FDA said NfL reduction insufficient for accelerated approval

CLNN

12/21/2023 - 07:05am

Clene announces peer-reviewed publication on CNM-Au8 brain target

CLNN

12/14/2023 - 08:39am

Clene price target lowered to $7 from $10 at Roth MKM

CLNN

11/7/2023 - 13:20pm

Clene expects cash to fund operations into 3Q24

CLNN

11/7/2023 - 08:03am

Clene reports Q3 EPS (2c), consensus (9c)

CLNN

11/7/2023 - 08:03am

Clene awarded $45.1M four-year grant from NINDS for CNM-Au8

CLNN

10/5/2023 - 10:05am

Clene announces publication on CNM-Au8 catalytic mechanism of action

CLNN

9/28/2023 - 08:05am